Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid

BACKGROUND: Cytarabine is used in the treatment of acute myeloid leukemia (AML). Low-dose cytarabine can be combined with valproic acid and all-trans retinoic acid (ATRA) as AML-stabilizing treatment. We have investigated the possible risk of immunotoxicity by this combination. We examined the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ersvaer, Elisabeth, Brenner, Annette K, Vetås, Kristin, Reikvam, Håkon, Bruserud, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422044/
https://www.ncbi.nlm.nih.gov/pubmed/25934555
http://dx.doi.org/10.1186/s40360-015-0012-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422044/
https://www.ncbi.nlm.nih.gov/pubmed/25934555
http://dx.doi.org/10.1186/s40360-015-0012-2

Ejemplares similares